Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Ath

2 clinical trials in Ath, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ath at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Ath

Open in trial search
Countries:BelgiumBelgium
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Institut Jules Bordet
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Ath

What the registry says about research in the country

01 Ath
Cardiovascular and Cerebrovascular Research
Clinical research in Ath addresses critical cardiovascular conditions, particularly focusing on cerebrovascular events. Investigations center on acute ischemic stroke and high-risk transient ischemic attack, conditions that represent significant causes of disability and mortality. These studies aim to evaluate novel therapeutic approaches designed to reduce the risk of recurrent ischemic events in patients who have experienced these serious cerebrovascular incidents. Assessment of innovative pharmacological interventions for stroke prevention Evaluation of treatment strategies to minimize recurrent cerebrovascular events Investigation of therapeutic efficacy in acute cerebrovascular conditions Research focused on improving outcomes for patients with transient ischemic attacks The research underway seeks to establish safer and more effective treatment protocols for individuals at elevated risk of stroke, potentially improving long-term neurological outcomes and quality of life for affected patients.
Oncology and Gastrointestinal Cancer Research
Ath hosts clinical investigations in the field of oncology, with particular emphasis on gastrointestinal malignancies. Research efforts concentrate on locally advanced rectal cancer, examining treatment strategies tailored to specific patient populations. These trials explore different approaches to neoadjuvant therapy, which involves treatment administered before surgical intervention, aiming to optimize the balance between treatment effectiveness and patient safety. Comparison of conventional neoadjuvant therapy versus total neoadjuvant therapy approaches Evaluation of treatment efficacy and safety profiles in older cancer populations Investigation of optimal timing and sequencing of chemotherapy and radiation therapy Research on personalized treatment strategies for rectal cancer management These studies are particularly significant as they address the unique needs of older patients with rectal cancer, seeking to identify treatment regimens that maximize therapeutic benefit while minimizing adverse effects in this vulnerable population.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.